NCT01357616View on ClinicalTrials.gov

Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

328

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Brinzolamide 1% / Timolol 0.5% fixed combination ophthalmic suspension

DRUG

Brinzolamide 1% ophthalmic suspension

DRUG

Timolol 0.5% ophthalmic solution

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY